BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6621769)

  • 1. Differential effect of cholesterol on two types of 5-hydroxytryptamine binding sites.
    Shih JC; Ohsawa R
    Neurochem Res; 1983 Jun; 8(6):701-10. PubMed ID: 6621769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of multiple binding sites for [3H]5-hydroxytryptamine in the rat CNS.
    Blurton PA; Wood MD
    J Neurochem; 1986 May; 46(5):1392-8. PubMed ID: 3958711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ; Snyder SH
    Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro.
    Leysen JE
    J Physiol (Paris); 1981; 77(2-3):351-62. PubMed ID: 7288650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain.
    Peroutka SJ; Snyder SH
    Brain Res; 1981 Mar; 208(2):339-47. PubMed ID: 7214150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple 3H-5-hydroxytryptamine binding sites in rat brain.
    Nelson DL; Pedigo NW; Yamamura HI
    J Physiol (Paris); 1981; 77(2-3):369-72. PubMed ID: 7288652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of subacute treatment with toluene on central monoamine receptors in the rat. Reduced affinity in [3H]5-hydroxytryptamine binding sites and in [3H]spiperone binding sites linked to dopamine receptors.
    Celani MF; Fuxe K; Agnati LF; Andersson K; Hansson T; Gustafsson JA; Battistini N; Eneroth P
    Toxicol Lett; 1983 Jul; 17(3-4):275-81. PubMed ID: 6623522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
    Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
    Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature-dependent 5-hydroxytryptamine (5-HT)-sensitive [3H]spiperone binding to rat cortical membranes: regulation by guanine nucleotide and antidepressant treatment.
    Kendall DA; Nahorski SR
    J Pharmacol Exp Ther; 1983 Nov; 227(2):429-34. PubMed ID: 6631722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A trifluoromethylphenyl piperazine derivative with high affinity for 5-hydroxytryptamine-1A sites in rat brain.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1985 Mar; 44(3):875-80. PubMed ID: 3838340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necessity of ascorbic acid in the radioligand binding assay for [3H]5-hydroxytryptamine.
    Andresen JW; Shih JC
    Neuropharmacology; 1986 Aug; 25(8):869-75. PubMed ID: 3774116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the pharmacological characteristics of 5 HT1 and 5 HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release.
    Martin LL; Sanders-Bush E
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(3):165-70. PubMed ID: 7155196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of [3H]5-hydroxytryptamine and [3H]spiperone binding sites in clathrin-coated vesicles from bovine brain.
    Moroi K; Ozaki N; Kadota T; Kadota K
    Brain Res; 1998 Jun; 794(2):291-8. PubMed ID: 9622654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual effects of ascorbate on serotonin and spiperone binding in rat cortical membranes.
    Muakkassah-Kelly SF; Andresen JW; Shih JC; Hochstein P
    J Neurochem; 1983 Nov; 41(5):1429-39. PubMed ID: 6413657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence on 5-[3H]hydroxytryptamine binding site development in chick embryo by serotonergic compounds.
    Soblosky JS; Jeng I
    J Neurochem; 1985 Feb; 44(2):544-51. PubMed ID: 2578180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The [3H]5-HT and [3H]spiroperidol binding sites in the rat frontal cortex and thermally inactivated at different rates.
    Poller D; Carroll JA; Middlemiss DN
    Eur J Pharmacol; 1981 Jun; 72(1):121-3. PubMed ID: 7262190
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple states of the 5-hydroxytryptamine1 receptor as indicated by the effects of GTP on [3H]5-hydroxytryptamine binding in rat frontal cortex.
    Sills MA; Wolfe BB; Frazer A
    Mol Pharmacol; 1984 Jul; 26(1):10-8. PubMed ID: 6749126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of solubilized serotonin (S2) receptors in rat brain.
    Ilien B; Gorissen H; Laduron PM
    Mol Pharmacol; 1982 Sep; 22(2):243-9. PubMed ID: 7144728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain.
    Pedigo NW; Yamamura HI; Nelson DL
    J Neurochem; 1981 Jan; 36(1):220-6. PubMed ID: 7463047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.